Pfizer and BioNTech said their Covid-19 vaccine was effective as a booster against the Omicron variant in children ages 5 to 11
Children under five in the U.S. aren’t yet eligible for a Covid-19 vaccine after efforts to get the shots to market have hit setbacks. WSJ’s Peter Loftus explains what we know about the vaccines and when they might become available. Photo composite: Todd JohnsonA booster dose of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE generated a strong immune response in children 5 to 11 years old, an encouraging sign for youngsters to maintain protection against the virus.
The companies said Thursday that a late-stage study of a booster found the extra shot significantly increased antibody levels against the Omicron variant. The shot also raised antibody supply against the initial strain the vaccines were designed to fight.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsNEW: Pfizer says it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
Consulte Mais informação »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsPfizer said Thursday it wants to expand its COVID-19 booster shots to healthy children ages 5-11.
Consulte Mais informação »
Pfizer to seek COVID-19 booster for healthy 5- to 11-year-oldsPfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
Consulte Mais informação »
Covid booster shot bolsters protection in 5-to-11-year-olds, Pfizer and BioNTech sayThe third shot appears to broaden the ability of the immune system to recognize variants such as omicron.
Consulte Mais informação »
Pfizer aims to expand COVID booster shot to healthy kids ages 5 to 11Pfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized COVID-19 shot.
Consulte Mais informação »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsNow Pfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized shot.
Consulte Mais informação »